AHA GUIDELINES Bundle (free trial)

Perioperative Cardiovascular Evaluation

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/434384

Contents of this Issue

Navigation

Page 4 of 15

3 Table 2. Supplemental Preoperative Evaluation Recommendations COR LOE Multivariate Risk Indices A validated risk-prediction tool can be useful in predicting the risk of perioperative MACE in patients undergoing noncardiac surgery. IIa B For patients with a low risk of perioperative MACE, further testing is NOT recommended before the planned operation. III: No Benefit B e 12-lead ECG Preoperative resting 12-lead ECG is reasonable for patients with known coronary heart disease, significant arrhythmia, peripheral arterial disease, cerebrovascular disease, or other significant structural heart disease, except for those undergoing low-risk surgery. IIa B Preoperative resting 12-lead ECG may be considered for asymptomatic patients without known coronary heart disease, except for those undergoing low-risk surgery. IIb B Routine preoperative resting 12-lead ECG is NOT useful for asymptomatic patients without known coronary heart disease, except for those undergoing low-risk surgery. III: No Benefit B Assessment of LV function It is reasonable for patients with dyspnea of unknown origin to undergo preoperative evaluation of LV function. IIa C It is reasonable for patients with HF with worsening dyspnea or other change in clinical status to undergo preoperative evaluation of LV function. IIa C Reassessment of LV function in clinically stable patients with previously documented LV dysfunction may be considered if there has been no assessment within a year. IIb C Routine preoperative evaluation of LV function is NOT recommended. III: No Benefit B Exercise stress testing for myocardial ischemia and functional capacity For patients with elevated risk and excellent (>10 METs) functional capacity, it is reasonable to forgo further exercise testing with cardiac imaging and proceed to surgery. IIa B For patients with elevated risk and unknown functional capacity it may be reasonable to perform exercise testing to assess for functional capacity if it will change management. IIb B For patients with elevated risk and moderate to good (≥4 METs to 10 METs) functional capacity, it may be reasonable to forgo further exercise testing with cardiac imaging and proceed to surgery. IIb B For patients with elevated risk and poor or unknown functional capacity it may be reasonable to perform exercise testing with cardiac imaging to assess for myocardial ischemia. IIb C Routine screening with noninvasive stress testing is NOT useful for patients at low-risk for noncardiac surgery. III: No Benefit B

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Perioperative Cardiovascular Evaluation